Omega-3 fatty acids (EPA and DHA specifically) have more peer-reviewed evidence in dogs than any other supplement category — documented benefits across joint disease, allergic skin disease, cardiac disease, kidney disease, cancer, cognitive dysfunction, and inflammatory bowel disease. But the dose required varies significantly by condition, and most dogs receive far less than the therapeutic amount needed to produce clinical benefit.
EPA vs. DHA: why both matter and which does what
Fish oil provides both EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) — two distinct compounds with overlapping but non-identical actions:
- EPA: Primary anti-inflammatory fatty acid — competitively inhibits arachidonic acid conversion to prostaglandins (PGE2) and leukotrienes (LTB4). Most relevant for joint disease, allergic disease, and cardiac inflammatory burden.
- DHA: Primary structural fatty acid — dominates neuronal membranes, photoreceptor membranes, and cardiac muscle cell membranes. Most relevant for cognitive dysfunction, eye health, and cardiac structural support.
Both are needed. Flaxseed oil provides ALA — an omega-3 that dogs convert to EPA and DHA at less than 5% efficiency. Fish oil and algae oil provide pre-formed EPA and DHA and are the only effective sources for dogs.
Dose by weight and condition
| Dog weight | Maintenance dose (EPA+DHA) | Therapeutic dose (EPA+DHA) |
|---|---|---|
| 10 lbs | 200 mg/day | 400 mg/day |
| 20 lbs | 400 mg/day | 800 mg/day |
| 30 lbs | 600 mg/day | 1,200 mg/day |
| 50 lbs | 1,000 mg/day | 2,000 mg/day |
| 75 lbs | 1,500 mg/day | 3,000 mg/day |
| 100 lbs | 2,000 mg/day | 4,000 mg/day |
Use the maintenance dose for healthy dogs and prevention. Use the therapeutic dose for confirmed joint disease, active allergies, cardiac disease, kidney disease, IBD, or cancer. A standard 1000mg fish oil capsule typically contains 300mg EPA+DHA — so a 50-lb dog on therapeutic dose needs approximately 7 capsules daily (or a concentrated product).
Condition-specific evidence
Joint disease: The most studied application. Omega-3 reduces inflammatory cytokine production in synovial fluid — measurable reductions in PGE2 and substance P in supplemented arthritic dogs. Therapeutic dose at 40mg/lb shows the most consistent results in veterinary literature.
Allergic skin disease: Reduces both immediate (mast cell-mediated) and delayed (T-cell-mediated) allergic responses. Synergistic with quercetin — together they address more of the allergic inflammatory cascade than either alone. Timeline: 8–12 weeks to full effect.
Cardiac disease: ACVIM recommends omega-3 for dogs with confirmed cardiac disease. Reduces inflammatory cytokine production, reduces cardiac cachexia, and supports cardiac muscle efficiency. DCM-affected dogs: ~40mg/lb daily.
Kidney disease: IRIS (International Renal Interest Society) recommends omega-3 for CKD Stage 2+. Reduces renal inflammatory burden and may slow glomerular filtration rate decline.
Cognitive dysfunction: DHA supplementation produces measurable improvements in cognitive assessment scores in senior dogs. The neuronal membrane maintenance effect is most clinically relevant here.
Signs of omega-3 deficiency
Dull, dry coat; excessive shedding; flaky skin; slow wound healing; chronic low-grade inflammation; chronic ear infections; recurring skin infections — these are all associated with omega-3 deficiency or insufficiency in dogs on standard commercial diets.
Related: omega-3 dosing guide · fish oil guide · best fish oil for dogs · fish oil vs krill vs algae · allergy supplement guide.
